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In both cases, restoration of one or a few peptides
had widely divergent results in fetal thymic organ culture
(FTOC): some peptides did not affect positive selectionIn this issue of Immunity, Don Wiley and colleagues
at all, whereas others restored a considerable degree of(Ding et al., 1998) describe a remarkable finding: the
positive selection, although all of them increased MHCstructure of a T cell receptor (TCR) in which 16 of 17
class I expression. In the TAP knockout mice, a mixturepeptide/major histocompatibility complex (MHC) con-
of two peptides that bound to different MHC class Itact residues differ from those of the original TCR ana-
molecules could restore positive selection of CD8 T cellslyzed by this team (Garboczi et al., 1996), yet the same
to 30%±50% of normal levels. However, when peptidespeptide/MHC complex in the same orientation is bound
eluted from thymic stroma were used to reconstituteby both TCRs. These two TCRs were derived from two
peptide/MHC complex expression in the TAP knockoutdifferent patients, although the significance of this factor
system, full restoration of positive selection was ob-is not clear. Because TCR specificity is believed to be
served in FTOC. In the case of the b2m knockout mice,determined by the amino acids that make contact with
mixtures of synthetic peptides of increasing complexitythe antigenic complex of peptide and MHC molecule,
restored positive selection of the numbers of CD8 T cellshow is it possible that both TCRs can recognize the
to near normal. Thus, it was established early that thesame peptide/MHC complex?
selection of CD8 T cells occurred on peptide/MHC com-There are two types of answer to this question. The
plexes, and that the most effective peptides for positive
first is the subject of the Wiley laboratory's thorough
selection of CD8 T cells were those eluted from the MHCdiscussion of their results. The second answer, as I
molecules expressed in the normal thymus.believe and will argue in this minireview, is that the
These studies were extended to include specific Tstrong similarity in antigen recognition between these
cells by using mice transgenic for a TCR of known speci-
two HLA-A2/Tax peptide recognition sites that differ
ficity. In this approach, a single peptide could be used
in nearly all of their peptide/MHC contact residues is
to influence selection of the TCR in FTOC. In the most
due to positive selection on a single self-peptide/self-
compelling case, it was determined that positive selec-
MHC complex. Self-peptide/self-MHC complexes are
tion could be driven by peptides that interact with the
expressed on thymic cortical epithelial cells (Laufer et
receptor but fail to activate mature T cells, but not by
al., 1996), and such complexes drive positive selection
agonist peptides that activate them, since these would
within the thymus. Theyare also expressed in theperiph- be expected to induce CD8 T cell deletion (Jameson et
ery, apparently by dendritic cells (Broker, 1997), and al., 1994). Subsequently, the same group used a ªdull-
there they drive the long-term survival of peripheral T ingº assay combined with sophisticated molecular char-
cells. Although TCRs such as these that differ exten- acterization to determine the nature of one naturally
sively in contact residues may represent an extreme occurring self-peptide that is a candidate for a peptide
case, there is evidence from other systems that such that may positively select transgenic thymocytes (Hog-
ªsynonymousº TCRs exist in several different settings, quist et al., 1997). Recently, it was shown that specific
possibly accounting for several phenomena such as im- recognition of thymic self-peptides can induce positive
munodominance (Busch and Pamer, 1998) and the role intrathymic selection of CD8 cytotoxic T cells (Hu et al.,
of the MHC in autoimmunity. 1997). Thus, it is clear that in the case of CD8 T cells,
positive intrathymic selection on self-peptide/self-MHC
Positive Intrathymic Selection on complexes can produce a mature TCR repertoire.
Self-Peptide/Self-MHC Complexes Similar studies have been carried out in the MHC class
The two TCRs in question both recognize the same Tax II±mediated positive selection of CD4 T cells; complex
peptide bound to HLA-A2, an MHC class I molecule, and mixtures of peptides drive a broad and highly variable
therefore must come from CD8 T cells. When positive TCR repertoire in vivo, while single peptide/MHC class
selection of CD8 T cells was analyzed in vitro, it was II mice produced either by covalent linkage of a known
found that CD8 T cells of non-TCR transgenic mice are MHC class II±binding peptide (Ignatowicz et al., 1996)
selected most strongly by the mixture of self-peptides or by deletion of the a chain of the peptide exchange
bound to self-MHC class I molecules (Ashton-Rickardt factor H-2M (Fung-Leung et al., 1996; Martin et al., 1996;
et al., 1993; Hogquist et al., 1993). These investigators Miyazaki et al., 1996) select a repertoire that is domi-
destroyed the ability of MHC class Imolecules to present nated by mature T cells that respond to self-MHC stimu-
peptides for positive selection, either by interfering with lators expressing a random set of self-peptides. These
transport of the peptides across theendoplasmic reticu- data originally were interpreted to mean that negative
selection was the dominant force in shaping the mature
TCR repertoire, since the majority (up to 70%) of such*To whom correspondence should be addressed (e-mail: charles.
janeway@yale.edu). cells reacted tosyngeneic stimulatorcells with a random
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set of self-peptides, and such cells would normally have distinguished from positive intrathymic selection since
it does not require specific self-peptide/self-MHC com-been deleted during their maturation in normal mice.
This interpretation was tested in an elegant experi- plexes, requires only that the b chain be rearranged in
the correct reading frame in order to generate b chainment published in Cell (Zerhann et al., 1997), in which
T cells were raised in the absence of all MHC molecules protein. This apparently explains earlier results in which
a transgenic b chain that lacked a V region could pro-by using MHC class I± and class II±deficient mice; in
such mice, no mature T cells develop. However, when mote the development of double-positive thymocytes
(Jacobs et al., 1994). The pre-TCR is functional since itfetal thymocytes were incubated with anti-TCR and anti-
CD4 antibodies, the thymocytes became CD4 T cells allows double-negative thymocytes that have produc-
tively rearranged their TCR b chains to respond to un-that apparently had no constraints on their usage of
TCR genes by either positive or negative selection. Such known stimuli that lead to expansion of the pool of thy-
mocytes by driving several rounds of division. Duringcells had a ªnormalº level of alloreactivity and also ªau-
toreactivityº in that they reacted to any tested haplotype this proliferative phase of thymocyte maturation, RAG-2
protein is degraded, and Rag1 and Rag2 mRNAs areat the 1%±10% level, which has been known to be the
frequency of alloreactive T cells since this number was repressed, preventing further b chain gene rearrange-
ment, since the rearrangements are dependent on thefirst reported by two groups (Ford and Atkins, 1971;
Wilson et al., 1978). When T cells were raised in the expression of both RAG proteins. Also during this pro-
cess, the CD4 and CD8 coreceptor genes are turned on.presence of I-Ab, this had no influence ontheir responses
to other alleles at I-A, but eliminated the response to Once the cells cease dividing and revert to a small
double-positive state, the a chains begin to rearrange.I-Ab. This demonstrated that MHC recognition was an
intrinsic property of TCR genes rather than the product Then positive selection occurs on those few T cells
whose ab TCRs are specific for the correct combinationof either positive or negative selection. However, the
system used could not answer questions about the role of self-peptide bound to self-MHC class II molecules.
When a transgenic TCR b chain is inserted into theof positive or negative selection in normal settings.
An alternative interpretation to the results in the sin- germline of a mouse, all of the T cells can undergo
b selection because they are already provided with agle-peptide mice was that the normal TCR repertoire,
which is positively selected on self-peptide/self-MHC transgene-encoded rearranged b chain. Thus, by fixing
the b chain by means of transgenesis, analysis of TCRclass II complexes (Laufer et al., 1996), was constrained
by positive selection in the presence of a single or limited a chain sequence yields information about the specific-
ity of the TCR repertoire in mature, single-positive thy-number of peptide/MHC class II proteins. That such
constraints occur in the thymi of single-peptide mice mocytes as well as peripheral, mature CD4 T cells.
was reported recently in a study in which the sequences
of a chain joins were highly constrained in postselection
Other Examples of ªSynonymousº T Cell Receptorsthymic cells as well as in peripheral T cells of b chain
During the characterization of T cell hybrids derivedtransgenic mice deficient in the peptide exchange factor
from single-chain TCR transgenic mice prepared fromH-2M (Sant'Angelo et al., 1997). Similar constraints were
the rearranged b chain of a clone that was specific fornot observed in the absence of the b chain transgene
the 81±104 peptide of cytochrome c, immunization withor in the presence of H-2M. Nevertheless, these mice
this peptide produced a collection of a chains that weregenerated normal numbers of T cellswith a normal distri-
identical at the amino acid level to the a chain in thebution of T cell maturational phenotypes. This led to a
parental clone but differed in nucleotide sequence (Jor-very different interpretation of the results obtained with
gensen et al., 1992). Similar results were obtained whensingle-peptide mice; rather than selecting a broad reper-
TCR b chain transgenic mice that were derived fromtoire of TCRs, the repertoire was highly constrained. The
the D10 TCR were immunized with peptide 134±146 offormer conclusion was based on the finding of a diverse
conalbumin to which D10 responds (Sant'Angelo et al.,set of b chains in both the TCRs of single-peptide mice
1996). When peptides mutant toward the N-terminusand those of normal mice. Nevertheless, even though
were used for immunization of these mice, then thethey produced all of their TCRs with a single b chain
sequence of the a chain obtained from peptide-specificsequence, the mice had an identical number of thymo-
T cell hybrids differed from that of the parental clone atcytes and peripheral T cells and equivalent T cell re-
the amino acid level, but all of the hybrids produced thesponses to I-Ab±bearing stimulator cellswhen compared
same amino acid sequence, although it was encodedto the wild-type, H-2M±deficient mice.
in several different nucleotide sequences (Jorgensen et
al., 1992; Sant'Angelo et al., 1996). However, when a
chain transgenic mice were immunized with peptidesb Selection Explains the Results in TCR b Chain
Transgenic Mice that had single amino acid changes near the C-terminus
of the peptide, it was found that the accompanying bThe process of b selection relies on the presence of an
in-frame b chain join that can encode b chain protein. chains used different Vb gene segments (Jorgensen et
al., 1992) or used the the same Vb gene segment withb chain protein can form a pre-TCR by pairing with the
pre-Ta chain and CD3 (Mombaerts et al., 1992; Mallick various V(D)J junctions (Sant'Angelo et al., 1996). These
results are consistent with crystal structures of TCR/et al., 1993; Dudley et al., 1994; Fehling et al., 1995;
Hoffman et al., 1996). T cells normally rearrange their b MHC class I/peptide complexes, which show that the
C-terminal half of the peptide is contacted mainly bychains before proceeding with a chain gene rearrange-
ment. The process called b selection, which should be the CDR3 of the TCR b chain, with minimal contacts
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with CDR1 and none with CDR2 (Garboczi et al., 1996), ªagonistº peptides, which induce full activation of the
cognate T cells.although no such structures exist for TCR/MHC class
II/peptide complexes. After several laboratories had investigated single
amino acid changes in peptides, it was then asked howThese results are direct predictions of the b selection
hypothesis in the two single-chain transgenic mice, many residues were really essential to bind a given TCR
(Evavold et al., 1995)? It was found that peptides withsince a transgenic b chain can drive b selection as effi-
ciently as in a wild-type mouse. In fact, there are indica- as few as one conserved amino acid residue could be
recognized by a given TCR, when this residue was posi-tions that the transgenic b chain may be more efficient
than normal b chains, because all of the expressed tioned properly in the peptide, and the peptide was
constructed so that it bound to the same MHC molecule.transgene-encoded rearranged b chains are in-frame,
whereas a fraction of cells with naturally rearranged b The only residue that literally could not be changed was
the central amino acid residue of the peptide, whichchains will have b chains that are not in the correct
reading frame, and such cells will die as a result of their makes complex interactions with the CDR3 regions of
both chains of the TCR (Garcia et al., 1996, 1998; Sant'-failure to produce a pre-TCR. By contrast, in an a chain
transgenic mouse, the process of b selection will not Angelo et al., 1996). Thus, there is remarkable flexibility
in peptide structure that can lead to T cell recognition.be efficient, since the a chain needs not to rearrange
but only to pair with the in-frame b chain and recognize Another study involved cloned T cell lines from patients
with multiple sclerosis (Wucherpfennig and Strominger,a self-peptide/self-MHC ligand.
Another example of apparently synonymous recep- 1995). Using these T cell lines, the authors searched
a database of viral proteins from unrelated infectioustors comes from immunization of normal mice with moth
cytochrome c, in which TCRs characterized by the use agents for peptides that were candidates to stimulate
these clones. From this search they found seven differ-of the same Vb3 and Va11 used in all such responses
were obtained in measurable quantities; however, there ent peptides that could stimulate the T cell clones de-
rived from various patients. The sequences of thesewas some variability in the amino acid residues in the
respective CDR3s. Although this was used as a way peptides bore only a passingresemblance to the peptide
to which the T cell clones were stimulated in vitro duringto track T cells after priming with moth cytochrome c
peptide, it was yet another example of synonymous their generation. Their interpretation was that the infec-
tious organism had activated an immune response thatTCRs recognizing the same peptide using similar but not
identical CDR3s (McHeyzer-Williams and Davis, 1995). by chance cross-reacted with a self-antigen. This spec-
ulation, which has been around for many years, is re-
ferred to as ªmolecular mimicry.º Whether molecular
The Same TCR Can Recognize mimicry plays a pathogenetic role in any autoimmune
a Variety of Peptides disease is an open question at the present time.
As there are examples of TCRs that recognize the same
peptide while they differ in sequence and V gene seg-
ment usage, so there are examples of single TCRs that Two Different TCRs Can Bind the Same
Peptide/MHC Complexcan recognize a variety of different peptides. This work
on peptide recognition began as an exploration of the I return last to the case that focused our attention in the
first place on the mystery of how two TCRs that are soflexibility of the TCR. This excercise produced several
interesting findings. The first is that most peptides could different can bind the same peptide/MHC class I ligand
in a similar orientation (Garboczi et al., 1996; Ding et al.,be modified at certain positions and retain T cell re-
ceptor recognition, while modifications at certain other 1998). In my opinion, positive intrathymic selection on
the same peptide can, in normal mice, lead to whatpositions prevented recognition altogether. In general,
peptides that could still bind to the presenting MHC appears to be a highly diverse repertoire of TCRs, due
to the initial rearrangement of the TCR b chain. Thismolecule retained the ability to stimulate a particular T
cell clone, while modification of TCR contacting resi- leads to T cells with similar recognition properties but
diverse TCRs. This is seen also in single-peptide micedues, especially the central amino acid at positions 4
or 5 of the peptide, were very sensitive to changes in in which a diversity of TCRs recognize similar peptides.
Presumably, the sequences of these TCRs will be highlysequence, and most residues substituted at this position
were inactive in stimulating the cognate T cell clone. The distinct from one another, although how distinct they
are is unclear at the present time. Suffice it to say thatsecond finding of interest is the frequent observation of
alterations in peptide sequence that could not activate if two such different TCRs can recognize the same exact
peptide/MHC complex, then attempts to modify T cella cloned T cell line fully but that could induce a partial
activation program. This made it obvious that such al- responses using strategies targeted at a particular TCR
are unlikely to succeed. However, strategies that usetered ligands were recognized by the TCR, but only a
partial signal was delivered. Such peptides are generally antigen to manipulate the immune response look more
favorable than they did initially, since the range of pep-referred to as partial agonists, partial antagonists, or
altered peptide ligands. The third finding of interest is tides that can be recognized appears to be limited, and
within these limitations, perhaps the most important isthat some of these altered peptide ligands were actually
fully antagonistic of T cell activation by the wild-type the repertoire of self-peptides expressed within the
thymus.peptide ligand presented on competent antigen-pre-
senting cells. Such peptides are referred to as ªanta- These examples of ªsynonymousº TCRs dramatically
affirm that it is the repertoire of self-peptides that selectsgonistº peptides, to distinguish them from so-called
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